Status:
TERMINATED
Catheter Ablation of Ventricular Arrhythmia Reduces Skin Sympathetic Activity
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
Cedars-Sinai Medical Center
Conditions:
Ventricular Tachycardia
Eligibility:
All Genders
18+ years
Brief Summary
This study is being done to determine whether there is an increase in sympathetic nerve activity before the onset of ventricular arrhythmias or irregular heartbeat rhythm. In addition, this study is l...
Eligibility Criteria
Inclusion
- Patients who have non-sustained or sustained VA (VA ≥ 30s or receiving appropriate ICD therapies) are presented to the clinic or admitted to the hospital within 7 days of episodes.
- The causes of VA are associated with structural heart diseases including ischemic or nonischemic cardiomyopathy (idiopathic cardiomyopathy, hypertrophic cardiomyopathy, cardiac sarcoidosis or amyloidosis, and arrhythmogentic right ventricular dysplasia).
- Subjects are 18 years of age and older.
Exclusion
- Female patients who is pregnant or of childbearing potential and not on a reliable form of birth control.
- Allergic to skin patch electrodes.
- Vulnerable populations (fetuses, neonates, pregnant women, prisoners, institutionalized individuals).
Key Trial Info
Start Date :
November 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04837183
Start Date
November 15 2021
End Date
January 1 2024
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905